The lung is a common site of complications of systemic connective tissue disease (CTD),
and lung involvement can present in several ways. Interstitial lung disease (ILD) and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can give rise to
different clinical manifestations that are directly related to viral tissue damage or indirectly …

Objective Clinically amyopathic dermatomyositis (CADM) is a subset of dermatomyositis
(DM) presenting with the characteristic rash of DM without objective muscle weakness …

Abstract Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical
phenotypes in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical …

The prognosis of patients with connective tissue disease (CTD) has improved significantly in
recent years, but interstitial lung disease (ILD) associated with connective tissue disease …

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and
clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases …

Objective: This study was conducted to identify the characteristics and prognosis of rapidly
progressive interstitial lung disease (RP-ILD) in idiopathic inflammatory myopathy (IIM) and …

Lung ailments in rheumatic diseases present unique challenges for diagnosis and
management and are a source of significant morbidity and mortality for patients. Unlike the …

Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

Objective. To determine the clinical features associated with the antimelanoma
differentiation-associated gene 5 antibody (anti-MDA5) in US patients with clinically …